HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

HER2DX and pCR in HER2-positive breast cancer: a combined analysis of 4 neoadjuvant studiesПодробнее

Independent validation of the HER2DX genomic test in HER2-positive breast cancerПодробнее

HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients ...Подробнее

#ESMO21 Expert Video Report on HER2-positive early breast cancerПодробнее

The association of the HER2DX signatures with survival in TNBCПодробнее

Assessing a Case of Early-Stage HER2+ Breast CancerПодробнее

Early Stage HER2-positive Breast CancerПодробнее

HER2DX risk-score in early-stage HER2-positive breast cancerПодробнее

HER2-Positive Breast Cancer: A Paradigm Shift in Diagnosis and TherapyПодробнее

How the IHC Test Could Change Your Breast Cancer Treatment | HER2-Positive Explained!Подробнее

HER2+ TreatmentПодробнее

HER2+ Early-Stage Breast Cancer: Peri-Operative TherapyПодробнее

Diagnosis of HER2+/ER- Early Breast CancerПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

HER2 Positive Breast Cancer ManagementПодробнее

Case 1: Treatment for Early-Stage HER2+ Breast CancerПодробнее

Practical Management of Early Stage HER2+ Breast CancerПодробнее

Anthracyclines for HER2-Positive Early Breast CancerПодробнее